Navigation Links
Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year

Company Named 2008 Medical Products Industry Leader

DEERFIELD, Ill., Sept. 5 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: BAX) announced today that it has been named 2008 Medical Products Industry Leader of the Dow Jones Sustainability World Index (DJSI World) and the Dow Jones Sustainability North America Index (DJSI North America). This marks the tenth consecutive year that the company has been listed in the DJSI and the seventh year the company has been named Medical Products Industry Leader since the launch of the DJSI in 1999.

Baxter's leadership position resulted from best scores across a number of performance areas including bioethics, codes of conduct, environmental policy/management, occupational health and safety, and social and environmental reporting.

"We believe our efforts in sustainability enhance shareholder value by making Baxter a more competitive company," said Robert L. Parkinson, Jr., Baxter's chairman and chief executive officer. "Baxter's approach to sustainability inspires innovation and discipline, and reflects the quality of our people and our company culture."

The Dow Jones Sustainability indices, derived from the Dow Jones Global Index, are the world's first benchmarks tracking the financial performance of leading sustainability-driven companies worldwide. The DJSI World Index tracks the financial performance of the top 10 percent of the 2,500 largest companies in the Dow Jones Global Index in terms of social, economic and environmental performance. The DJSI North America Index includes the top 20 percent in each of 57 sectors out of the largest 600 North American companies in the Dow Jones Global Index.

In addition to Baxter's inclusion in the DJSI, the company has been recognized by Innovest Strategic Value Advisors as one of the Global 100 Most Sustainable Corporations in the World and by Corporate Responsibility Officer magazine as one of the 100 Best Corporate Citizens in the United States. Baxter is a member of the Center for Corporate Citizenship at Boston College, the Business Environmental Leadership Council of the Pew Center on Global Climate Exchange, the Chicago Climate Exchange, the U.S. EPA's Climate Leaders, the Ethics & Compliance Officer Association and Hospitals for a Healthy Environment. Baxter endorses the Ceres principles and is an organizational stakeholder of the Global Reporting Initiative.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Baxter Announces Licensing Agreement for Innocolls Gentamicin Surgical Implant in the United States
2. Baxter Declares Quarterly Dividend
3. Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
4. Bioniche Pharma Acquires Baxters ENLON(R) and ENLON-PLUS(R)
5. Baxters Board of Directors Declares Quarterly Dividend
6. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
7. Baxters V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals
8. Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
9. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
10. Baxter and Its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs Locally and Globally
11. Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
Post Your Comments:
(Date:12/1/2015)... 1, 2015 Frost & Sullivan is ... program addresses ways companies can innovate and transform ... --> ... --> ... well as the disrupting factors altering the industry, ...
(Date:12/1/2015)... , Dec. 1, 2015  CardioCell LLC, a ... stem cells for cardiovascular indications, intends to proceed ... based on recommendations from a Heart Failure Advisory ... Scientific Advisory Board members . In a ... Phase IIa safety and efficacy data from CardioCell,s ...
(Date:12/1/2015)...  Symic, a clinical-stage biotherapeutics company developing multiple compounds ... announced that it has secured $25 million in a ... its lead candidates SB-030 and SB-061. The financing was ... all existing major investors, as well as several new ... by Symic to over $43 million since being founded ...
(Date:12/1/2015)... ... December 01, 2015 , ... Matthew “Tex” VerMilyea, PhD, HCLD, has joined Texas ... oversee all IVF lab procedures as well as continue his research efforts into the ... miles to Auckland, New Zealand to bring home a High Complexity Clinical Laboratory Director ...
Breaking Biology Technology:
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Sensors - Technology and Patent Infringement Risk Analysis" ... --> Fingerprint sensors using capacitive technology ... fingerprint sensor vendor Idex forecasts an increase of 360% ... devices and of the fingerprint sensor market between 2014 ...
(Date:11/18/2015)... new scientific discoveries deepen our understanding of how cancer ... challenges in better using that knowledge to guide treatment ... children continue to survive pediatric cancer, that counseling may ... John M. Maris, M.D ., a pediatric oncologist ... --> John M. Maris, M.D ., ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
Breaking Biology News(10 mins):